Literature DB >> 3952624

Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow.

J P Muizelaar, D P Becker.   

Abstract

The best treatment for symptomatic cerebral ischemia from presumed vasospasm after aneurysmal subarachnoid hemorrhage remains a matter of controversy. A direct effect of any treatment modality on regional cerebral blood flow has never been documented. In a series of 43 patients operated on for ruptured anterior circulation aneurysms, five patients (11.6%) developed clinical signs of cerebral ischemia postoperatively. In four of those patients, the diagnosis of "vasospasm" was made with measurements of cerebral blood flow (133Xe inhalation or intravenous injection, 10-16 detectors, cerebral blood flow infinity). Treatment with induced arterial hypertension with phenylephrine was instituted. Hemodilution was instituted in one patient; the other three patients already had hematocrits in the range of 33. Within 1 hour, the cerebral blood flow measurement was repeated to document the effect of treatment. The average pretreatment hemispherical blood flow on the operated side was 18.8 mL/100 g per minute, on the contralateral side 21.0 mL/100 g per minute. With treatment these flows increased to 30.8 and 35.8 mL/100 g per minute, respectively. There was also an immediate and obvious positive clinical effect in all patients. The role of measurement of cerebral blood flow in the clinical management of vasospasm is discussed. We stress the theoretical and practical advances of measurements of cerebral blood flow over cerebral angiography, especially in comatose patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3952624     DOI: 10.1016/0090-3019(86)90205-3

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  21 in total

Review 1.  Hemodynamic management of subarachnoid hemorrhage.

Authors:  Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report.

Authors:  D K Song; M R Harrigan; J P Deveikis; J E McGillicuddy
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

3.  The combined effects of hypertension, hemodilution, and osmotherapy on the metabolic sequelae of acute experimental cerebral ischemia.

Authors:  S Ehteshami; B S Aspey; C M Hurst; A L McCoy; M J Harrison
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

4.  Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: a randomized controlled pilot study.

Authors:  Nelly Rondeau; Raphaël Cinotti; Bertrand Rozec; Antoine Roquilly; Hervé Floch; Nicolas Groleau; Patrick Michel; Karim Asehnoune; Yvonnick Blanloeil
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 5.  Haemodynamic considerations in the management of patients with subarachnoid haemorrhage.

Authors:  D P Archer; D A Shaw; R L Leblanc; B I Tranmer
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

6.  Early aneurysm surgery: a 7 year clinical practice report.

Authors:  J M Gilsbach; A G Harders; H R Eggert; M E Hornyak
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

7.  On the effect of calcium antagonists on cerebral blood flow in rats. A comparison of nimodipine and flunarizine.

Authors:  M Zumkeller; H E Heissler; H Dietz
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

Review 8.  Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.

Authors:  Jan W Dankbaar; Arjen Jc Slooter; Gabriel Je Rinkel; Irene C van der Schaaf
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

9.  Neurogenic Cardiac Injury.

Authors:  Nader M. Banki; Jonathan G. Zaroff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-12

10.  Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.

Authors:  Kelly Goodson; Marc Lapointe; Timothy Monroe; Julio A Chalela
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.